Why Abzena?
Trust our focused approach.
We ensure compliance with biopharmaceutical regulations for cGMP biologic manufacturing and commercial biologics manufacturing operations. Our dedicated technical teams focus on ensuring your program meets both clinical and commercial goals.
We operate a network of aligned facilities that support biologics commercial manufacturing needs across the lifecycle of your molecule.
By de-risking your program, we ensure technology transfer from your facility to ours, or within our network, is successful and meets all product quality requirements.
Abzena’s Quality organization delivers safe and compliant products to support both clinical and commercial biologics manufacturing programs.
Our Quality organization provides a comprehensive suite of quality services to ensure full compliance with regulatory requirements.
Alongside this expertise, we offer the technologies and analytical capabilities needed to support a wide range of modalities, from straightforward molecules to the most complex.
Our modern, single-use facility located in San Diego, CA, deploys the latest in technology and processing, including high titer processing, continuous manufacturing, and perfusion.
Our upstream facilities include Single Use Bioreactors from 50L to 2000L. Our downstream process capabilities include chromatography ranging up to 80cm columns.
We offer industry-leading analytical capabilities such as LC-MS (Orbitrap, QTOF, MALDITOF, QQQ and Q), biolayer interferometry, (u)HPLC, CE, iCIEF and SoloVPE.
Commercial biologics manufacturing involves producing biologic therapies at the scale, quality, and consistency required for global commercial supply.
Abzena provides cGMP facilities, advanced single-use systems, and technical expertise to deliver reliable clinical through commercial biologics manufacturing programs.
Our facility uses high-titer processing, continuous manufacturing, perfusion, and scalable upstream and downstream systems suited for commercial supply.
Abzena’s Quality organization provides end-to-end oversight to ensure all products meet regulatory standards and commercial release criteria.
The asset you’re developing right now can make a real difference for human health. Let us apply our wealth of experience to accelerate and maximize its potential.